A case report of immunotherapy-related breast reactive capillary endothelial proliferation
Reactive capillary endothelial proliferation (RCEP) is the most common immune-related adverse event (irAE) during Camrelizumab treatment. RCEP occurs in the majority of patients with advanced solid tumors who receive Camrelizumab monotherapy. This irAE mainly occurs in the skin clinically, and RCEP...
Saved in:
| Main Authors: | Chen JIE, Jing YU, Ru-Meng LI, Jun GONG, Cong-Hua XIE |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of New Medicine
2023-02-01
|
| Series: | Yixue xinzhi zazhi |
| Subjects: | |
| Online Access: | https://yxxz.whuznhmedj.com/futureApi/storage/attach/2302/XxOqFquz1qmFfjHsPR3gIrZjMjcRug5Zp5O0CZd7.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Endothelial Damage in Sepsis: The Interplay of Coagulopathy, Capillary Leak, and Vasoplegia—A Physiopathological Study
by: Gianni Turcato, et al.
Published: (2025-06-01) -
Corrigendum: Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma
by: Tongshan Wang, et al.
Published: (2024-12-01) -
Camrelizumab, an Anti‐PD‐1 Monoclonal Antibody, Plus Carboplatin and Nab‐Paclitaxel as First‐Line Setting for Extensive‐Stage Small‐Cell Lung Cancer: A Phase 2 Trial and Biomarker Analysis
by: Jia Yu, et al.
Published: (2025-08-01) -
Efficacy and safety of camrelizumab for the treatment of cervical cancer: a systematic review and meta-analysis
by: Xiaodong Mi, et al.
Published: (2024-12-01) -
Zebrafish model for functional screening of flow-responsive genes controlling endothelial cell proliferation
by: George Bowley, et al.
Published: (2024-12-01)